Daprodustat for patients with heart failure and renal Anemia: A pilot multicenter, open-label, randomized controlled study
{{output}}
Background: Anemia and renal failure, common comorbidities in patients with heart failure (HF), are associated with increased mortality. Hypoxia-inducible factor prolyl hydroxylase inhibitors, such as daprodustat, treat renal ane... ...
